Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Dec 12;26(4):632–641. doi: 10.1158/1055-9965.EPI-16-0520

Table 2.

5-year incidence rates (2009–2013) for men and women by age

<55* 55–64 65–74 75+




N Rate N Rate RR 95% CI N Rate RR 95% CI N Rate RR 95% CI
Men
Esophagus
  Adenocarcinoma 644 0.8 1,348 11.4 14.9 (13.5, 16.4) 1,381 21.6 28.2 (25.7, 31.0) 1,288 27.8 36.3 (33.0, 40.0)
  Squamous Cell 218 0.3 525 4.4 17.7 (15.1, 20.9) 545 8.5 34.1 (29.0, 40.1) 515 11.1 44.5 (37.9, 52.4)
  Other 32 0.0 85 0.7 19.0 (12.5, 29.6) 95 1.5 39.2 (25.9, 60.7) 96 2.1 54.3 (35.9, 83.9)
Kidney & Renal Pelvis
  Kidney, NOS 5144 6.3 5503 46.6 7.4 (7.1, 7.7) 5148 80.0 12.8 (12.3, 13.3) 3838 83.2 13.3 (12.7, 13.8)
  Renal Pelvis 80 0.1 214 1.8 19.3 (14.8, 25.2) 325 5.1 54.3 (42.3, 70.4) 472 10.1 107.6 (84.6, 138.3)
Lung
  Squamous 819 0.9 2,722 23.0 24.4 (22.5, 26.4) 4,532 72.1 76.5 (70.9, 82.5) 5,006 108.4 114.9 (106.6, 123.9)
  Small cell 579 0.7 1,577 13.3 19.9 (18.1, 22.0) 2,236 35.0 52.4 (47.7, 57.5) 1,801 39.1 58.5 (53.2, 64.3)
  Adenocarcinoma 2,205 2.6 5,267 44.5 17.3 (16.4, 18.1) 7,247 114.3 44.3 (42.2, 46.5) 7,571 163.9 63.5 (60.5, 66.6)
  Large cell 104 0.1 238 2.0 16.6 (13.1, 21.1) 310 4.8 39.9 (31.8, 50.4) 277 6.0 49.7 (39.5, 62.9)
  Malignant neoplasm &
  Carcinoma unspecified
608 0.7 1,518 12.8 18.1 (16.4, 19.9) 2,009 31.6 44.5 (40.6, 48.8) 2,381 51.2 72.0 (65.8, 78.9)
Thyroid
  Papillary 3,352 4.2 1,415 12.0 2.9 (2.7, 3.1) 986 15.3 3.7 (3.4, 3.9) 479 10.4 2.5 (2.3, 2.8)
  Follicular 246 0.3 126 1.1 3.5 (2.8, 4.4) 112 1.8 5.8 (4.6, 7.3) 81 1.8 5.9 (4.5, 7.6)
  Medullary 97 0.1 34 0.3 2.4 (1.6, 3.6) 28 0.4 3.6 (2.3, 5.6) 21 0.5 3.8 (2.3, 6.2)
  Anaplastic 15 0.0 20 0.2 10.0 (4.8, 21.1) 33 0.5 29.8 (15.6, 59.2) 31 0.7 39.5 (20.5, 78.7)

Women

Breast
  HR+/HER2+ 4790 5.9 2,902 22.9 3.9 (3.7, 4.1) 1,911 25.4 4.3 (4.1, 4.6) 1,459 21.0 3.6 (3.4, 3.8)
  HR−/HER2+ 1985 2.4 1,399 11.1 4.6 (4.3, 4.9) 828 11.0 4.6 (4.2, 5.0) 653 9.5 3.9 (3.6, 4.3)
  HR+/HER2− 24,066 29.1 20,796 163.5 5.6 (5.5, 5.7) 19,592 262.6 9.0 (8.9, 9.2) 16,501 240.3 8.3 (8.1, 8.4)
  Triple negative 4840 5.9 3201 25.2 4.3 (4.1, 4.4) 2274 30.4 5.1 (4.9, 5.4) 1923 27.6 4.7 (4.4, 4.9)
Esophagus
  Adenocarcinoma 102 0.1 181 1.4 12.0 (9.3, 15.5) 187 2.6 21.6 (16.8, 27.8) 318 4.3 36.3 (28.8, 45.9)
  Squamous Cell 116 0.1 239 1.9 14.4 (11.5, 18.2) 321 4.4 33.7 (27.1, 42.1) 390 5.5 42.2 (34.1, 52.5)
  Other 10 0.0 15 0.1 10.3 (4.3, 25.7) 24 0.3 30.1 (13.7, 70.6) 62 0.9 76.5 (38.4, 168.0)
Kidney & Renal Pelvis
  Kidney, NOS 2853 3.5 2682 21.1 6.1 (5.8, 6.4) 2681 36.2 10.5 (9.9, 11.1) 2697 38.9 11.3 (10.7, 11.9)
  Renal Pelvis 48 0.1 97 0.8 13.6 (9.5, 19.7) 218 3.0 53.3 (38.7, 74.6) 459 6.4 113.9 (84.1, 157.2)
Lung
  Squamous 428 0.5 1,283 10.0 20.8 (18.6, 23.2) 2,781 38.0 78.7 (71.0, 87.3) 3,435 51.3 106.1 (95.8, 117.7)
  Small cell 626 0.7 1,472 11.5 16.3 (14.9, 18.0) 2,107 28.5 40.4 (36.9, 44.3) 1,884 28.6 40.4 (36.9, 44.4)
  Adenocarcinoma 2,851 3.3 5,440 42.7 13.0 (12.4, 13.6) 7,787 106.0 32.3 (30.9, 33.7) 8,759 128.9 39.3 (37.6, 41.0)
  Large cell 88 0.1 190 1.5 14.8 (11.4, 19.3) 227 3.1 30.2 (23.4, 39.1) 244 3.7 36.4 (28.3, 47.1)
  Malignant neoplasm &
  Carcinoma unspecified
568 0.6 1,030 8.1 12.4 (11.2, 13.8) 1,499 20.5 31.6 (28.7, 34.9) 2,039 29.5 45.4 (41.3, 50.0)
Thyroid
  Papillary 13,586 16.9 3,910 30.9 1.8 (1.8, 1.9) 2,244 29.6 1.8 (1.7, 1.8) 1,007 15.5 0.9 (0.9, 1.0)
  Follicular 778 1.0 260 2.1 2.1 (1.9, 2.5) 226 3.1 3.2 (2.7, 3.7) 147 2.3 2.4 (2.0, 2.8)
  Medullary 132 0.2 72 0.6 3.5 (2.6, 4.7) 57 0.8 4.8 (3.4, 6.6) 31 0.5 2.9 (1.8, 4.3)
  Anaplastic 9 0.0 28 0.2 21.3 (9.7, 51.6) 45 0.6 61.7 (29.4, 144.3) 85 1.1 110.7 (54.8, 252.0)
*

Reference group